Table of Content

1 Report Prologue
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
2.4 Market Size Estimation
2.5 Forecast Model
3 Market Dynamics
3.1 Introduction
3.2 Drivers
3.2.1 Bleeding disorder and related conditions will push the demands on health systems (Impact weightage 75%)
3.2.2 Rising funding, healthcare insurance coverage, and awareness programs for bleeding disorders are expected to boost the growth of the market (Impact weightage 25%)
3.3 Restrains
3.3.1 Lack of R&D capabilities: (Impact weightage 45%)
3.3.2 Counterfeit Drugs (Impact weightage 35%)
3.3.3 Lack of Awareness (Impact weightage 20%)
4 Middle East & Africa Blood Coagulants Market By Type
4.1 Introduction
4.2 Coagulation Factor
4.2.1 Recombinant Coagulation Factor
4.2.2 Plasma Derived Coagulation Factor
5 Middle East & Africa Blood Coagulants Market, By Indication
5.1 Introduction
5.2 Haemophilia
5.3 Surgery
5.4 Other Bleeding Disorders
6 Middle East & Africa Blood Coagulants Market, By Country
6.1 Introduction
6.2 Saudi Arabia (KSA)
6.3 United Arab Emirates (UAE)
6.4 Qatar
6.5 Oman
6.6 Kuwait
6.7 Egypt
6.8 Rest of Middle East & Africa
7 Company Profiles
7.1 Pfizer
7.1.1 Company Overview
7.1.2 Financials
7.1.3 Products
7.1.4 Strategies
7.1.5 Key Developments
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financials
7.2.3 Products
7.2.4 Strategies
7.2.5 Key Developments
7.3 Novo Nordisk AS
7.3.1 Company Overview
7.3.2 Financials
7.3.3 Products
7.3.4 Strategies
7.3.5 Key Developments
7.4 Shire
7.4.1 Company Overview
7.4.2 Financials
7.4.3 Products
7.4.4 Strategies
7.5 SOBI
7.5.1 Company Overview
7.5.2 Financials
7.5.3 Products
7.5.4 Strategies
7.5.5 Key Developments
7.6 Octapharma
7.6.1 Company Overview
7.6.2 Financials
7.6.3 Products
7.6.4 Strategies
7.6.5 Key Developments
7.7 CSL Limited
7.7.1 Company Overview
7.7.2 Financials
7.7.3 Products
7.7.4 Strategies
7.7.5 Key Developments



List of Figures



FIGURE 1 RESEARCH PROCESS OF MRFR
FIGURE 2 MIDDLE EAST & AFRICA MARKET: FORECAST MODEL
FIGURE 3 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY TYPE, 2016 & 2023 (USD MILLION)
FIGURE 4 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY TYPE, 2016 & 2023 (USD MILLION)
FIGURE 5 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY INDICATION, 2016 & 2023 (USD MILLION)
FIGURE 5 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET, BY COUNTRY, 2016 & 2023 (USD MILLION)

 

List of Tables



TABLE 1 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY COUNTRIES, 2014 TO 2023 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA RECOMBINANT COAGULATION FACTOR MARKET BY COUNTRIES, 2014 TO 2023 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA PLASMA DERIVED COAGULATION FACTOR MARKET BY COUNTRIES, 2014 TO 2023 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR HAEMOPHILIA BY COUNTRY, 2014 TO 2023 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR SURGERY BY COUNTRY, 2014 TO 2023 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR OTHER BLEEDING DISORDERS BY COUNTRY, 2014 TO 2023 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET, BY COUNTRY, 2014 TO 2023 (USD MILLION)
TABLE 11 SAUDI ARABIA BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 12 SAUDI ARABIA COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 13 SAUDI ARABIA BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 14 UNITED ARAB EMIRATES BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 15 UNITED ARAB EMIRATES COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 16 UNITED ARAB EMIRATES BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 17 QATAR BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 18 QATAR COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 19 QATAR BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 20 OMAN BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 21 OMAN COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 22 OMAN BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 23 KUWAIT BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 24 KUWAIT COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 25 KUWAIT BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 26 EGYPT BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 27 EGYPT COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 28 EGYPT BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 29 REST OF MEA BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 30 REST OF MEA COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 31 REST OF MEA BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)